首页> 外国专利> Reduction and treatment of ischemic reperfusion lung disorder by multipotent hepatocytes

Reduction and treatment of ischemic reperfusion lung disorder by multipotent hepatocytes

机译:多能肝细胞减少和治疗缺血性再灌注性肺疾病

摘要

It is an object of the present invention to provide a novel medical chart using multipass hepatocytes (Muse cells) in regenerative medicine. The present invention provides a cell preparation and a medicinal composition for alleviating and treating ischemic reperfusion injury comprising SSEA-3 positive pluripotent hepatocytes isolated from a mesenchymal tissue of a living body or cultured mesenchymal cells. The cell preparation of the present invention is based on a constitution in which a subject having the above-mentioned disease is induced to lung tissue by administering Muse cells to alleviate and cure the disease.
机译:本发明的目的是提供一种在再生医学中使用多程肝细胞(Muse细胞)的新颖医学图表。本发明提供了用于减轻和治疗缺血再灌注损伤的细胞制剂和药物组合物,其包含从活体的间充质组织或培养的间充质细胞中分离的SSEA-3阳性多能肝细胞。本发明的细胞制剂是基于这样的构造,其中通过给予Muse细胞以减轻和治愈该疾病,将具有上述疾病的对象诱导至肺组织。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号